Design, Synthesis and SAR of New Potent HIV-1 RT Inhibitors

被引：0

作者：

Chimirri, Alba ^{[1
]}

De clercq, Erik ^{[2
]}

Maga, Giovanni ^{[3
]}

Logoteta, Patrizia ^{[1
]}

Ferro, Stefania ^{[1
]}

De Luca, Laura ^{[1
]}

Iraci, Nunzio ^{[1
]}

Pannecouque, Christophe ^{[2
]}

Monforte, Annamaria ^{[1
]}

机构：

[1] Univ Messina, Messina, Italy

[2] Katholieke Univ Leuven, Louvain, Belgium

[3] CNR, IGM, I-27100 Pavia, Italy

来源：

ANTIVIRAL RESEARCH | 2009年 / 82卷 / 02期

关键词：

D O I：

10.1016/j.antiviral.2009.02.133

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

128

引用

页码：A56 / A57

页数：2

共 50 条

[1] DESIGN AND SYNTHESIS OF POTENT, ORALLY BIOAVAILABLE HIV-1 PROTEASE INHIBITORS
KALDOR, SW
KALISH, V
DRESSMAN, BA
FRITZ, JE
HAMMOND, M
CROWELL, TA
TATLOCK, J
REICH, S
DAVIES, J
APPELT, K
SHETTY, B
SU, KS
CAMPANALE, KM
BURGESS, JA
LUBBENHUSEN, PP
BAXTER, AJ
MUESING, MA
HATCH, SD
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 1994, 208 : 17 - MEDI
[2] SPECIFIC HIV-1 INHIBITORS TARGETED AT THE HIV-1 RT
DECLERCQ, E
JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES AND HUMAN RETROVIROLOGY, 1993, 6 (06): : 673 - 673
[3] Design and synthesis of novel and potent allosteric HIV-1 integrase inhibitors with a spirocyclic moiety
Adachi, Kaoru
Manabe, Tomoyuki
Yamasaki, Takayuki
Suma, Akira
Orita, Takuya
Furuzono, Tomoko
Adachi, Tsuyoshi
Ohata, Yoshitsugu
Akiyama, Yoshiyuki
Miyazaki, Susumu
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2024, 110
[4] Design and synthesis of bicyclic pyrimidinones as potent and orally bioavailable HIV-1 integrase inhibitors
Muraglia, Ester
Kinzel, Olaf
Gardelli, Cristina
Crescenzi, Benedetta
Donghi, Monica
Ferrara, Marco
Nizi, Emanuela
Orvieto, Federica
Pescatore, Giovanna
Laufer, Ralph
Gonzalez-Paz, Odalys
Di Marco, Annalise
Fiore, Fabrizio
Monteagudo, Edith
Fonsi, Massimiliano
Felock, Peter J.
Rowley, Michael
Summa, Vincenzo
JOURNAL OF MEDICINAL CHEMISTRY, 2008, 51 (04) : 861 - 874
[5] Synthesis of 1-(alkyl)-5-dimethylamino-6-phenethyluracils as potent nonnucleoside HIV-1 RT inhibitors
Wang, Xiaowei
Chen, Yanli
Guo, Ying
Li, Amin
Ma, Xiaoyan
Liu, Junyi
SYNTHETIC COMMUNICATIONS, 2007, 37 (14) : 2421 - 2431
[6] 3 NEW POTENT HIV-1 INHIBITORS FROM MYXOBACTERIA
JURKIEWICZ, E
JANSEN, R
KUNZE, B
TROWITZSCHKIENAST, W
FORCHE, E
REICHENBACH, H
HOFLE, G
HUNSMANN, G
ANTIVIRAL CHEMISTRY & CHEMOTHERAPY, 1992, 3 (04): : 189 - 193
[7] Design, synthesis and SAR study of bridged tricyclic pyrimidinone carboxamides as HIV-1 integrase inhibitors
Patel, Manoj
Naidu, B. Narasimhulu
Dicker, Ira
Higley, Helen
Lin, Zeyu
Terry, Brian
Protack, Tricia
Krystal, Mark
Jenkins, Susan
Parker, Dawn
Panja, Chiradeep
Rampulla, Richard
Mathur, Arvind
Meanwell, Nicholas A.
Walker, Michael A.
BIOORGANIC & MEDICINAL CHEMISTRY, 2020, 28 (13)
[8] Synthesis of a new class of HIV-1 inhibitors
Farese-Di Giorgio, A
Pairot, S
Patino, N
Condom, R
Di Giorgio, C
Aumelas, A
Aubertin, AM
Guedj, R
NUCLEOSIDES & NUCLEOTIDES, 1999, 18 (02): : 263 - 275
[9] Design and Synthesis of Piperazine Sulfonamide Cores Leading to Highly Potent HIV-1 Protease Inhibitors
Bungard, Christopher J.
Williams, Peter D.
Schulz, Jurgen
Wiscount, Catherine M.
Holloway, M. Katharine
Loughran, H. Marie
Manikowski, Jesse J.
Su, Hua-Poo
Bennett, David J.
Chang, Lehua
Chu, Xin-Jie
Crespo, Alejandro
Dwyer, Michael P.
Keertikar, Kartik
Morriello, Gregori J.
Stamford, Andrew W.
Waddell, Sherman T.
Zhong, Bin
Hu, Bin
Jo, Tao
Diamond, Tracy L.
Bahnck-Teets, Carolyn
Carroll, Steven S.
Fay, John F.
Min, Xu
Morris, William
Ballard, Jeanine E.
Miller, Michael D.
McCauley, John A.
ACS MEDICINAL CHEMISTRY LETTERS, 2017, 8 (12): : 1292 - 1297
[10] Design, synthesis and SAR of thienopyridines as potent CHK1 inhibitors
Zhao, Lianyun
Zhang, Yingxin
Dai, Chaoyang
Guzi, Timothy
Wiswell, Derek
Seghezzi, Wolfgang
Parry, David
Fischmann, Thierry
Siddiqui, M. Arshad
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2010, 20 (24) : 7216 - 7221

← 1 2 3 4 5 →